New study reveals a 29% prevalence of erectile dysfunction, a proportion higher than that of the general population.
Men prescribed 3 different phosphodiesterase type 5 inhibitors had nearly 3-fold increased odds of having a Charlson Comorbidity Index of 1 or higher than men not prescribed the drugs.
Data show that gout is associated with an increased risk of developing erectile dysfunction.
Collagenase clostridium histolyticum therapy is associated with significantly worse improvement in penile curvature in men with calcified plaques.
Only half of patients with initial treatment success maintain benefits at 2 years.
Men with erectile dysfunction (ED) are almost twice as likely to experience a cardiovascular event as those without ED.
At 1 year post-op, patients with MetS prior to prostate surgery had a significantly lower continence rate than those without MetS (75.4% vs 82.6%).
More than half of older adults surveyed agree that sex is important to their overall quality of life.
Unapproved erectile dysfunction drugs are touted as a "healthy man alternative to the little blue pill."
No significant effect for rosuvastatin, CandHCTZ, or both versus placebo in men aged 55 years.
Men with greater handgrip strength have a lower risk of erectile dysfunction (ED), new findings suggest.
Erectile function among men with vasculogenic erectile dysfunction improved significantly after 6 weeks of treatment with an aspirin dosage of 100 mg/day.
Decrease in scores on the Men's Sexual Health Questionnaire mostly due to ejaculation disorders.
In a study, men with Peyronie's disease who tadalafil 5 mg per day had decreased pain on erection and degree of penile curvature.
Meta-analysis of studies conducted around the world found that men with diabetes have more than 3.5 times increased risk for erectile dysfunction.
A new study found a 52% higher risk for the future development of Parkinson's disease among men with erectile dysfunction.
Long-term use of the drug may predispose men to worsening erectile dysfunction and elevated risk of diabetes and non-alcoholic fatty liver disease.
The risk for developing erectile dysfunction is 15% higher among men with than without gout.
While users had an overall 11% increased risk of melanoma, there wasn't evidence that the drugs cause melanoma.
Diabetic men receiving an inflatable penile prosthesis have a 69% increased risk of device-associated infection compared with non-diabetics.
Oral PDE5 inhibitors improve sperm parameters and can treat erectile dysfunction in men.
Men taking PDE5 lowered their risk of hospitalization and mortality after a heart attack by 33%.
Longer use of finasteride at a dosage of 1.25 mg/day or less among men younger than 42 years is associated with greater risk, study finds.
Chronic periodontitis was associated with 2.2-fold increased odds of ED.
The researchers found that high-sensitivity cardiac troponin I levels were significantly higher in participants with erectile dysfunction than in those without
A recent trial compared the effects of regular grapefruit juice with a low furanocoumarin hybrid grapefruit juice on midazolam.
The prevalence of ED is 30% higher among men who have vitamin D levels below 20 ng/mL versus those with levels of 30 ng/mL or higher.
Prostate cancer was diagnosed in 19.5% of PDE5i users vs 22.7% of nonusers, a statistically insignificant difference.
Low testosterone levels may be a contributing factor.
Researchers say skin cancer in these patients is likely due to more sun exposure.
Renal and Urology News Articles
- Gadolinium-Based Contrast May Up Acute Kidney Injury Risk in CKD
- Delayed Prostate Cancer Treatment May Up Relapse Risk
- Review: Desmopressin Decreases Nocturia Episodes
- Surgery, Radiation Regimens for High-Grade PCa Offer Similar Outcomes
- Salvage Prostatectomy May Benefit Some Prostate Cancer Patients
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)